Peptinovo Biopharma
About:
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.
Website: https://peptinovo.com
Description:
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects. The company has strong knowledge of the drug discovery and development process gained during the many years the founders worked for large pharmaceutical companies.
Total Funding Amount:
$1.32M
Headquarters Location:
Ann Arbor, Michigan, United States
Founded Date:
2014-01-01
Founders:
Bill Elliott, Reynold Homan
Number of Employees:
Last Funding Date:
2024-09-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai